iThriveMD Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.5/10
Best for: seeing what it charges before you answer any medical questions
iThriveMD scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. It charges from $299 a month; its compounded tirzepatide, at $399, is 48% above the $269 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
then $299/mo ongoing
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
In the price
Prices checked October 2026
iThriveMD bills compounded semaglutide at $299 and tirzepatide at $399 every 28 days, the same at every dose. The first month is $100 less. Prepaying 3, 6 or 12 months lowers the rate, and a 3-month microdose tirzepatide program costs $585. It runs local clinics as well as telehealth, with labs, hormones, peptides, NAD+ and IV therapy alongside. The first consultation is free. The compounding pharmacy is not named.
Is iThriveMD legit?
Yes. iThriveMD is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 6.5/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there an iThriveMD promo or coupon code?
iThriveMD has no coupon code to enter. New patients are currently quoted $199 for the first month, then $299 a month, and the discount applies on its own. Coupon sites advertising an "iThriveMD promo code" are not a source we can vouch for.
See how iThriveMD compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to iThriveMD
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Luvo Health
Best for: moving between compounded and brand without changing seller
Editorial score · methodology
iThriveMD at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Microdosing tirzepatide
- Starting price
- $299/mo
- Pricing model
- Flat: the price stays the same as the dose goes up
- What's included
- Medication · Consult · Shipping · Coaching
- FDA status
- No FDA warning letters found
How iThriveMD scores
Six columns, each one computed from something iThriveMD has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
2.2/10$399/month is 48% above the $269 median for compounded tirzepatide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
7.5/10A price is shown before the questionnaire starts. Baseline bloodwork is required before a prescription.
Trust & Safety15%
6.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
8.5/10The price covers the medication, clinician visits, shipping and coaching.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on iThriveMD
Last checked October 2026- Checked the listed price across 2 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for iThriveMD
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with iThriveMD involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1iThriveMD shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2The intake requires baseline bloodwork before a first prescription, which takes longer than a written form and is the more careful route.
- 3Ask iThriveMD which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 4The monthly price includes the medication, clinician visits, shipping and coaching.
- Lowest ongoing monthly price: semaglutide $299, tirzepatide $399. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that iThriveMD serves your state before you start.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting iThriveMD
- Phone
- 619-612-0672
Medications iThriveMD lists
iThriveMD lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Peptides iThriveMD offers
iThriveMD sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Pricing
Prices re-verified
$199 the first month ($100 off), then $299 every 28 days, no long-term commitment. Prepaid: 3-month $269.10, 6-month $254.15, 12-month $239.20 a month, shipped every 28 days.
$299 the first month ($100 off), then $399 every 28 days. Prepaid: 3-month $299.25, 6-month $259.35, 12-month $199.50 a month. Microdose program: $585 for 12 weeks.
Check the price yourself before you pay
Every figure here comes from iThriveMD's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits, shipping and coaching
- We found no FDA warning letters issued to iThriveMD
- Baseline bloodwork is required before a prescription
Against it
- Semaglutide costs $299 a month, 50% above the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $399 a month, 48% above the $269 median for compounded tirzepatide across the sellers we compare
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What iThriveMD charges
The figure iThriveMD leads with is $199, and it is a first-month rate. From month two the price is $299/month, which is the number to plan around. There is nothing wrong with an introductory offer; it just is not the price of staying on the medication.
- Compounded semaglutide: $199 first month, then $299/month
- Compounded tirzepatide: $299 first month, then $399/month
For compounded tirzepatide, the median across the sellers we compare is $269/month, so iThriveMD's $399 is a premium, and a premium has to buy something. Discounting the first month does not change the twelve-month total by much. For scale, the dearest tenth of compounded sellers charges about three times the cheapest tenth.
Direct Meds dispenses semaglutide and tirzepatide from $249/month, which makes it the fair comparison to run before you commit here.
What iThriveMD dispenses
iThriveMD prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy.
Safety and disclosure
iThriveMD tells you its price before you start the medical questionnaire. It also offers coaching as part of the plan. We found no FDA warning letters issued to iThriveMD. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If iThriveMD will not tell you, treat that as a warning sign. Once you have the pharmacy's name, 503A vs 503B explains which regulator oversees it and how to check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
iThriveMD also sells NAD+, and a 2026 systematic review found no outcomes trials of injected NAD+ for anti-aging or wellness.
Who should look elsewhere
- You care most about the twelve-month total, not the first bill. A flat-rate seller such as Collective will usually win that math.
- You would be choosing on the advertised figure. The introductory month is real, but it is not what you will pay in month three.
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether iThriveMD bills your plan before you start.
It fits if
- you want the price to stop moving as your dose climbs
- you want a cheap way to find out whether the medication suits you before committing
- you want coaching bundled in rather than billed on top
Our read
iThriveMD is a cheap way to start and an ordinary way to continue. Use the $199 month for what it is good for, finding out whether the medication works for you, and re-run the numbers against $299/month before you let it renew twice. MangoRx is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
iThriveMD scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. It charges from $299 a month; its compounded tirzepatide, at $399, is 48% above the $269 median among the sellers we compare.
Before you pay iThriveMD
Starting at $299 a month. Check today's price, then start the intake.
Where iThriveMD is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
If none of these fits, our guide to alternatives to iThriveMD sets more sellers in the same category beside iThriveMD on price, states and what the price includes.
Frequently Asked Questions
How to check iThriveMD yourself
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this iThriveMD review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See iThriveMD's current pricing
Plans start at $199 a month. Whether you qualify is a clinician's decision, made after your intake.